An investigational drug-eluting stent called Xience, coated with everolimus, led to significantly less late lumen loss after nine months than did the Taxus (paclitaxel-eluting) stent, said researchers here today. March 2007
An investigational bioabsorbable magnesium coronary stent worked as advertised for several months but led to a higher revascularization rate at one year.
Evaluation of Cypher Sirolimus Eluting Stent in Patients Undergoing Elective Revascularization of Nonacute Total Coronary Occlusions (TCO). Cordis Corp. Columbia Presbyterian, NYC. 2006-2011. (Not currently recruiting)